MIND recognizes Cure Alzheimer’s Fund with first philanthropic award

Established in 2001 by members of the Harvard Medical School faculty, the MassGeneral Institute for Neurodegenerative Disease (MIND) recently recognized the Cure Alzheimer’s Fund with its first Philanthropic Innovation and Investment Award. The award recognizes donors who have made substantial commitments to visionary work that cannot be funded through other sources but has the potential to radically change scientific thinking and drug discovery for neurodegenerative disease.

The Cure Alzheimer’s Fund, which aims to slow, stop, or reverse the disease by 2016, has generously supported Massachusetts General Hospital’s Alzheimer’s research labs, including MIND’s Genetics and Aging Research Unit. Harvard scientists at the Genetics and Aging Research Unit are working to identify the full set of Alzheimer’s genes by 2008.